310 likes | 588 Views
Epidemiology of Diabetes Mellitus. b y Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga. Pathophysiology of Diabetes.
E N D
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga
Pathophysiology of Diabetes type 1, which results from autoimmune beta-cell destruction in the pancreas and is characterizedby a complete lack of insulin production; type 2, which develops whenthere is an abnormal increased resistanceto the action of insulinand the body cannot produceenough insulin to overcome the resistance; gestational diabetes, which is aform of glucose intolerance thataffects some women during pregnancy; and a group of other types of diabetescaused by specific genetic defectsof beta-cell function or insulin action,diseases of the pancreas, or drugs or chemicals
the new diagnostic criteria for type 2 diabetes are as follows: (ADA Revisions, Diabetes Care, Suppl, January 2010) • An A1c level of 6.5% or more. • Fasting plasma glucose level of 126 mg/dL or more. • A 2-hour plasma glucose level of 200 mg/dL or more after a 75-g oral glucose tolerance test. • A random plasma glucose level of 200 mg/dL or more in a patient with symptoms of hyperglycemia. • In the absence of symptoms of hyperglycemia, the first 3 options listed should be confirmed with repeated testing. • Patients with an A1c level between 5.7% and 6.4% should be considered to have prediabetes and should receive appropriate counseling on therapeutic lifestyle change.
Prevalensi DM di AS : 7% (20,8 juta penduduk) 14,6 juta DM dan 6,2 juta UDDM (30%) (sumber: Desphande, dkk. Phys Ther. 2008;88)
Mortality Overall, the risk of death among peoplewith diabetes is almost twice thatof people of similar age who do nothave diabetes. Duration of diabetesalso is an important determinant of mortality; younger age-of-onset groups (45 years of age) have an increased risk of premature death. Two thirds of people with diabetes die of heart diseaseand stroke. The risk for cardiovasculardisease mortality is 2 to 4times higher in people with diabetesthan in people who do not have diabetes.
Risk factors fortype 1 diabetes family history, race (with whites at higher riskthan other racial or ethnic groups), certain viral infections duringchildhood.
Risk factors for type 2diabetes • Nonmodifiable risk factors include : • age, incidence and prevalence increases with age. • race or ethnicity, • family history (genetic predisposition), • history of gestational diabetes, • and low birth weight. Diabetes • Modifiable or lifestyle risk factorsinclude: • increased body mass index(BMI), W/H ratio • physical inactivity, • poor nutrition, • hypertension, • smoking, • and alcohol use, • Depression, increased stress, lower soscial support, poor mental health
Complications Microvascular complications:- nervous system damage (neuropathy),- renal system damage (nephropathy) and - eye damage (retinopathy) Macrovascular complications: - cardiovascular disease, stroke, peripheral vascular disease. Peripheral vascular disease may lead to bruises or injuries that donot heal, gangrene, and, ultimately, amputation.
Control of Risk Factors toReduce Complications The 3 most significant risk factors are hyperglycemia, high blood pressure, and hypercholesterolemia. It has been suggested that improvements in glycemic control, blood pressure,and cholesterol level can reduce a person’s risk for complications. For example, in a person with diabetes,each percentage point reduction in glycosylated hemoglobin (Hb A1c) level can reduce that person’s risk for microvascular complications by 40%; a 10 mm Hg decrease in bloodpressure can reduce that person’srisk for any diabetic complication byup to 12%; and control of serum lipidscan reduce that person’s risk for cardiovascular complications by 20% to 50%. Clearly, better control ofthese risk factors in people with diabetescan lead to more favorable outcomes.
Burden to the Health Care System • the estimated costs associated with diabetes in the UnitedStates in 2002 totaled $132 billion,with direct medical costs of $92 billion and indirect costs (disability, loss in work productivity and premature mortality) of $40 billion. • these expenditures would be expected to reach approximately $192 billion by 2020. • Approximately 40% of the total costof diabetes in the United States is duedirectly to inpatient care for treatment of diabetes complications